[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 1969

Oral Administration of Pralidoxime Chloride in Echothiophate Iodide Therapy

Author Affiliations

From the Division of Ophthalmology (Drs. Lipson and Ellis) and the Department of Internal Medicine (Dr. Holmes), University of Colorado Medical Center, Denver.

Arch Ophthalmol. 1969;82(6):830-835. doi:10.1001/archopht.1969.00990020822019

A total of 19 patients receiving topically administered echothiophate iodide for control of chronic open angle glaucoma were treated with orally administered pralidoxime chloride (Protopam) to determine which small doses would reverse cholinesterase levels. One group of ten patients received 4.5 gm of pralidoxime chloride in divided doses weekly for four weeks. A second group of nine patients received 10.5 gm in divided doses weekly for three weeks. No significant changes in intraocular tension or facility of outflow were noted after pralidoxime chloride therapy, but a significant rise in erythrocyte cholinesterase activity (0.07 delta pH units; P < 0.01) was demonstrated. No significant toxic signs were noted. Clinical ramifications are discussed.

Leopold, I.H.; Gold, P.; and Gold, D.:  Use of a Thiophosphinyl Quaternary Compound (217-MI) in Treatment of Glaucoma , Arch Ophthal 58:363-366 ( (Sept) ) 1957.Article
Becker, B.; Pyle, G.; and Drews, R.:  The Tonographic Effect of Echothiophate (Phospholine) Iodide , Amer J Ophthal 47:635-640 ( (May) ) 1959.
Drance, S.M., and Carr, F.:  Effects of Phospholine-Iodide (217-MI) on Intraocular Pressure in Man , Amer J Ophthal 49:470-474 ( (March) ) 1960.
Lawlor, R.C., and Lee, P.F.:  Use of Echothiophate (Phospholine Iodide) in the Treatment of Glaucoma , Amer J Ophthal 49:808-813 ( (April) ) 1960.
Gray, L.F., and Robinson, J.P.:  The Clinical Evaluation of Echothiophate (Phospholine Iodide) in the Treatment of Glaucoma , Amer J Ophthal 49:1162-1165 ( (May) ) 1960.
Krishna, N., and Leopold, I.H.:  Echothiophate (Phospholine) Iodide (217-MI) in Treatment of Glaucoma: Further Observations , Arch Ophthal 62:300-313 ( (Aug) ) 1959.Article
Becker, B., and Gage, T.:  Demecarium Bromide and Echothiophate Iodide in Chronic Glaucoma , Arch Ophthal 63:102-107 ( (Jan) ) 1960.Article
Hiscox, P.E.A., and McCulloch, C.:  Cardiac Arrest Occurring in a Patient on Echothiophate Iodide Therapy , Amer J Ophthal 60:425-427 ( (Sept) ) 1965.
Leopold, I.H.:  Ocular Cholinesterase and Cholinesterase Inhibitors: The Friedenwald Memorial Lecture , Amer J Ophthal 51:885-919 ( (May) ) 1961.
DeRoetth, A., et al:  Blood Cholinesterase Activity of Glaucoma Patients Treated With Phospholine Iodide , Amer J Ophthal 62:834-838 ( (Nov) ) 1966.
Klendshoj, N.C., and Olmsted, E.P.:  Observations of Dangerous Side-Effects of Phospholine Iodide in Glaucoma Therapy , Amer J Ophthal 56:247-250 ( (Aug) ) 1963.
Humphreys, J.A., and Holmes, J.H.:  Systemic Effects Produced by Echothiophate Iodide in Treatment of Glaucoma , Arch Ophthal 69:737-743 ( (June) ) 1963.Article
DeRoetth, A., Jr., et al:  Effect of Phospholine Iodide on Blood Cholinesterase Levels of Normal and Glaucoma Subjects , Amer J Ophthal 59:586-592 ( (April) ) 1965.
Wahl, J.W., and Tyner, G.S.:  Echothiophate Iodide: The Effect of 0.0625% Solution of Blood Cholinesterase , Amer J Ophthal 60:419-425 ( (Sept) ) 1965.
Ellis, P.P, and Esterdahl, M.:  Echothiophate Iodide Therapy in Children: Effect Upon Blood Cholinesterase Levels , Arch Ophthal 77:598-601 ( (May) ) 1967.Article
Wilensky, J.G., et al:  Effect of Ocular Instillation of Echothiophate Iodide and Isoflurophate on Cholinesterase Activity of Various Rabbit Tissues , Amer J Ophthal 64:398-404 ( (Sept) ) 1967.
Mamo, J.G., and Leopold, I.H.:  Evaluation and Use of Oximes in Ophthalmology , Amer J Ophthal 46:724-731 ( (Nov) ) 1958.
Childs, A.F., et al:  The Reactivation by Oximes and Hydroxamic Acids of Cholinesterase Inhibited by Organo-Phosphorus Compounds , Brit J Pharmacol 10:462, 1955.
Kewitz, H.:  A Specific Antidote Against Lethal Alkyl Phosphate Intoxication: Repair of Chemical Lesion , Arch Biochem 66:263-270, 1957.Article
Michel, H.O.:  An Electrometric Method for the Determination of Red Blood Cell and Plasma Cholinesterase Activity , J Lab Clin Med 34:1564-1568, 1949.
Koelle, G.B.: " Anticholinesterase Agents ," in Goodman, L.S., and Gilman, A.: The Pharmacological Basis of Therapeutics , ed 3, New York: The Macmillan Co., 1965, pp 456-458.
Osserman, K.E., and Genkins, G.:  Studies in Myasthenia Gravis: Reduction in Mortality Rate After Crisis , JAMA 183:97-101 ( (Jan) ) 1963.Article
Jager, B.V., and Stagg, G.N.:  Toxicity of Diacetyl Monoxime and of Pyridine-2-Aldoxime Methiodide in Man , Bull Hopkins Hosp 102:203-211, 1958.
Jager, B.V., et al:  Studies on Distribution and Disappearance of Pyridine-2-Aldoxime Methiodide (PAM) and Diacetyl Monoxime (DAM) in Man and Experimental Animals , Bull Hopkins Hosp 102:225-234, 1958.
Wills, J.H.: Report From the Physiology Division, Directorate of Medical Research, US Army Chemical Research and Development Laboratories, Army Medical Center, Maryland, 1963.